Patents by Inventor Oluwole T. Aloba

Oluwole T. Aloba has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7799771
    Abstract: A pharmaceutical dosage unit for oral administration to a human female comprising a therapeutically effective amount of 17?-estradiol-3-lower alkanoate, most preferably 17?-estradiol-3-acetate, and a pharmaceutically acceptable carrier is disclosed. Also disclosed is a method for treating a human female in need of 17?-estradiol and a contraceptive method by oral administration of the pharmaceutical dosage unit and a method of preparing a pharmaceutical composition that may be used to form the pharmaceutical dosage unit of the invention.
    Type: Grant
    Filed: June 17, 2005
    Date of Patent: September 21, 2010
    Assignee: Warner Chilcott Company, LLC.
    Inventors: Oluwole T. Aloba, Tina M. deVries
  • Patent number: 7572779
    Abstract: A pharmaceutical dosage unit for oral administration to a human female comprising a therapeutically effective amount of 17?-estradiol-3-lower alkanoate, most preferably 17?-estradiol-3-acetate, and a pharmaceutically acceptable carrier is disclosed. Also disclosed is a method for treating a human female in need of 17?-estradiol and a contraceptive method by oral administration of the pharmaceutical dosage unit and a method of preparing a pharmaceutical composition that may be used to form the pharmaceutical dosage unit of the invention.
    Type: Grant
    Filed: April 29, 2004
    Date of Patent: August 11, 2009
    Assignee: Warner Chilcott Company LLC
    Inventors: Oluwole T. Aloba, Tina M deVries
  • Patent number: 6962908
    Abstract: A pharmaceutical dosage unit for oral administration to a human female comprising a therapeutically effective amount of 17?-estradiol-3-lower alkanoate, most preferably 17?-estradiol-3-acetate, and a pharmaceutically acceptable carrier is disclosed. Also disclosed is a method for treating a human female in need of 17?-estradiol and a contraceptive method by oral administration of the pharmaceutical dosage unit and a method of preparing a pharmaceutical composition that may be used to form the pharmaceutical dosage unit of the invention.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: November 8, 2005
    Assignee: Warner Chilcott Company Inc.
    Inventors: Oluwole T. Aloba, Tina M. deVries
  • Publication number: 20040209856
    Abstract: A pharmaceutical dosage unit for oral administration to a human female comprising a therapeutically effective amount of 17&bgr;-estradiol-3-lower alkanoate, most preferably 17&bgr;-estradiol-3-acetate, and a pharmaceutically acceptable carrier is disclosed. Also disclosed is a method for treating a human female in need of 17&bgr;-estradiol and a contraceptive method by oral administration of the pharmaceutical dosage unit and a method of preparing a pharmaceutical composition that may be used to form the pharmaceutical dosage unit of the invention.
    Type: Application
    Filed: April 29, 2004
    Publication date: October 21, 2004
    Applicant: Galen (Chemicals) Limited
    Inventors: Oluwole T. Aloba, Tina M. deVries
  • Publication number: 20030118638
    Abstract: A pharmaceutical dosage unit for oral administration to a human female comprising a therapeutically effective amount of 17&bgr;-estradiol-3-lower alkanoate, most preferably 17&bgr;-estradiol-3-acetate, and a pharmaceutically acceptable carrier is disclosed. Also disclosed is a method for treating a human female in need of 17&bgr;-estradiol and a contraceptive method by oral administration of the pharmaceutical dosage unit and a method of preparing a pharmaceutical composition that may be used to form the pharmaceutical dosage unit of the invention.
    Type: Application
    Filed: December 21, 2001
    Publication date: June 26, 2003
    Inventors: Oluwole T. Aloba, Tina M. deVries